Anti-Human KIRD2 Subgroup Recombinant Antibody
-
产品编号
YR1284
-
别名
科研级 Lirilumab ( 利瑞鲁单抗 ), Anti-KIRD2 Subgroup Recombinant Antibody, Research Grade Lirilumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Lirilumab ( 利瑞鲁单抗 ), Anti-KIRD2 Subgroup Recombinant Antibody, Research Grade Lirilumab |
| Catalog Number | YR1284 |
| Molecular Name | Lirilumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | Human IgG1 |
| Formulation | PBS, pH7.5 |
| Background | Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. |
| CAS Number | 1000676-41-4 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | KIRD2 Subgroup[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
